Literature DB >> 25744439

IgG Aggregation Mechanism for CHO Cell Lines Expressing Excess Heavy Chains.

Steven C L Ho1, Tianhua Wang, Zhiwei Song, Yuansheng Yang.   

Abstract

Aggregates in protein therapeutics like IgG monoclonal antibodies (mAb) are detrimental to product safety and efficacy. It has been reported that aggregates form in Chinese hamster ovary (CHO) cell lines expressing greater amount of heavy chain (HC) than light chain (LC). In this study, we observed that aggregates could form within the cells with excess HC and were partially secreted into the supernatant. The aggregates in the supernatant consisted of mainly HC and were partially dissociated under either reducing or denaturing conditions. Mutation of a predicted free cysteine on HC to prevent disulfide bonding did not reduce aggregation. Re-transfecting CHO cells with excess HC with more BiP, an important IgG molecular chaperone, partially reduced unwanted aggregates and fragments possibly by helping retain more incomplete products within the cell for either proper assembly or degradation. A second transfection of LC into CHO cells with excess HC to increase the LC expression to a level greater than the HC expression successfully removed all aggregates and fragments. mAb product aggregation in CHO cells with excess HC occur due to a combination of limited chaperones and LC:HC ratio. These results provide added insights to aggregate formation and would be useful for development of mAb cell lines with reduced aggregates.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25744439     DOI: 10.1007/s12033-015-9852-7

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Unassembled Ig heavy chains do not cycle from BiP in vivo but require light chains to trigger their release.

Authors:  M Vanhove; Y K Usherwood; L M Hendershot
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

3.  Protein aggregation during overexpression limited by peptide extensions with large net negative charge.

Authors:  Yian-Biao Zhang; Jason Howitt; Sean McCorkle; Paul Lawrence; Karen Springer; Paul Freimuth
Journal:  Protein Expr Purif       Date:  2004-08       Impact factor: 1.650

4.  Culture temperature modulates aggregation of recombinant antibody in cho cells.

Authors:  Natalia Gomez; Jayashree Subramanian; Jun Ouyang; Mary D H Nguyen; Matthew Hutchinson; Vikas K Sharma; Andy A Lin; Inn H Yuk
Journal:  Biotechnol Bioeng       Date:  2011-10-03       Impact factor: 4.530

5.  Aggregation-prone motifs in human immunoglobulin G.

Authors:  Naresh Chennamsetty; Bernhard Helk; Vladimir Voynov; Veysel Kayser; Bernhardt L Trout
Journal:  J Mol Biol       Date:  2009-06-13       Impact factor: 5.469

6.  Classification and characterization of therapeutic antibody aggregates.

Authors:  Marisa K Joubert; Quanzhou Luo; Yasser Nashed-Samuel; Jette Wypych; Linda O Narhi
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

7.  Protein disulfide isomerase does not control recombinant IgG4 productivity in mammalian cell lines.

Authors:  N V L Hayes; C M Smales; P Klappa
Journal:  Biotechnol Bioeng       Date:  2010-03-01       Impact factor: 4.530

8.  Effect of increased expression of protein disulfide isomerase and heavy chain binding protein on antibody secretion in a recombinant CHO cell line.

Authors:  Nicole Borth; Diethard Mattanovich; Renate Kunert; Hermann Katinger
Journal:  Biotechnol Prog       Date:  2005 Jan-Feb

9.  Kinetic model of BiP- and PDI-mediated protein folding and assembly.

Authors:  Ramon Gonz lez; Barbara A Andrews; Juan A Asenjo
Journal:  J Theor Biol       Date:  2002-02-21       Impact factor: 2.691

10.  Assembly and secretion of heavy chains that do not associate posttranslationally with immunoglobulin heavy chain-binding protein.

Authors:  L Hendershot; D Bole; G Köhler; J F Kearney
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

View more
  5 in total

Review 1.  Recombinant antibodies aggregation and overcoming strategies in CHO cells.

Authors:  Tingting Xu; Jihong Zhang; Tianyun Wang; Xiaoyin Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-24       Impact factor: 4.813

2.  Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design.

Authors:  Samira Ahmadi; Fatemeh Davami; Noushin Davoudi; Fatemeh Nematpour; Maryam Ahmadi; Saeedeh Ebadat; Kayhan Azadmanesh; Farzaneh Barkhordari; Fereidoun Mahboudi
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

3.  An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific binding.

Authors:  Guangcan Cao; Xinyu Gao; Yancheng Zhan; Qingguang Wang; Zhe Zhang; Dimiter S Dimitrov; Rui Gong
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

4.  Random epigenetic modulation of CHO cells by repeated knockdown of DNA methyltransferases increases population diversity and enables sorting of cells with higher production capacities.

Authors:  Marcus Weinguny; Peter Eisenhut; Gerald Klanert; Nikolaus Virgolini; Nicolas Marx; Andreas Jonsson; Daniel Ivansson; Ann Lövgren; Nicole Borth
Journal:  Biotechnol Bioeng       Date:  2020-07-24       Impact factor: 4.395

5.  Systematic use of synthetic 5'-UTR RNA structures to tune protein translation improves yield and quality of complex proteins in mammalian cell factories.

Authors:  Peter Eisenhut; Aman Mebrahtu; Mona Moradi Barzadd; Niklas Thalén; Gerald Klanert; Marcus Weinguny; Anna Sandegren; Chao Su; Diane Hatton; Nicole Borth; Johan Rockberg
Journal:  Nucleic Acids Res       Date:  2020-11-18       Impact factor: 19.160

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.